701 related articles for article (PubMed ID: 18337147)
1. [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
Marret S; Marpeau L; Follet-Bouhamed C; Cambonie G; Astruc D; Delaporte B; Bruel H; Guillois B; Pinquier D; Zupan-Simunek V; Bénichou J;
Gynecol Obstet Fertil; 2008 Mar; 36(3):278-88. PubMed ID: 18337147
[TBL] [Abstract][Full Text] [Related]
2. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*.
Marret S; Marpeau L; Zupan-Simunek V; Eurin D; Lévêque C; Hellot MF; Bénichou J;
BJOG; 2007 Mar; 114(3):310-8. PubMed ID: 17169012
[TBL] [Abstract][Full Text] [Related]
3. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
Crowther CA; Hiller JE; Doyle LW; Haslam RR;
JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
[TBL] [Abstract][Full Text] [Related]
4. Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and 5-year neurodevelopmental outcomes of very preterm infants: the EPIPAGE cohort study.
Foix-L'Hélias L; Marret S; Ancel PY; Marchand L; Arnaud C; Fresson J; Picaud JC; Rozé JC; Theret B; Burguet A; Larroque B; Kaminski M;
BJOG; 2008 Jan; 115(2):275-82. PubMed ID: 18081606
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of magnesium sulfate in women at risk of preterm delivery-neonatal cardiovascular effects.
Paradisis M; Osborn DA; Evans N; Kluckow M
J Perinatol; 2012 Sep; 32(9):665-70. PubMed ID: 22094492
[TBL] [Abstract][Full Text] [Related]
6. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
[TBL] [Abstract][Full Text] [Related]
7. Effects of antenatal magnesium sulfate therapy on cerebral and systemic hemodynamics in preterm newborns.
Shokry M; Elsedfy GO; Bassiouny MM; Anmin M; Abozid H
Acta Obstet Gynecol Scand; 2010 Jun; 89(6):801-6. PubMed ID: 20504082
[TBL] [Abstract][Full Text] [Related]
8. The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor.
Mittendorf R; Roizen NJ; Pryde PG
J Perinatol; 2004 Jul; 24(7):465-6. PubMed ID: 15224123
[No Abstract] [Full Text] [Related]
9. [Prevention of cerebral palsy using magnesium sulfate in pre-term newborns].
Marret S; Chollat C; Levèque C; Marpeau L
Arch Pediatr; 2011 Mar; 18(3):324-30. PubMed ID: 21257296
[TBL] [Abstract][Full Text] [Related]
10. [Extreme prematurity: comparison of outcome at 5 years depending on gestational age below or above 26 weeks].
Autret F; Kieffer F; Tasseau A; Rigourd V; Valleur D; Voyer M; Magny JF
Arch Pediatr; 2009 Jul; 16(7):976-83. PubMed ID: 19403280
[TBL] [Abstract][Full Text] [Related]
11. Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
Lorthe E; Torchin H; Delorme P; Ancel PY; Marchand-Martin L; Foix-L'Hélias L; Benhammou V; Gire C; d'Ercole C; Winer N; Sentilhes L; Subtil D; Goffinet F; Kayem G
Am J Obstet Gynecol; 2018 Sep; 219(3):298.e1-298.e14. PubMed ID: 29852153
[TBL] [Abstract][Full Text] [Related]
12. Antenatal magnesium sulphate neuroprotection in the preterm infant.
Marret S; Doyle LW; Crowther CA; Middleton P
Semin Fetal Neonatal Med; 2007 Aug; 12(4):311-7. PubMed ID: 17513184
[TBL] [Abstract][Full Text] [Related]
13. [Is it possible to protect the preterm infant brain and to decrease later neurodevelopmental disabilities?].
Marret S; Foix-L'hélias L; Ancel PY; Kaminski M; Larroque B; Marcou-Labarre A; Laudenbach V
Arch Pediatr; 2008 Jun; 15 Suppl 1():S31-41. PubMed ID: 18822257
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic administration to patients with preterm labor and intact membranes: is there a beneficial effect in patients with endocervical inflammation?
Ovalle A; Romero R; Gómez R; Martínez MA; Nien JK; Ferrand P; Aspillaga C; Figueroa J
J Matern Fetal Neonatal Med; 2006 Aug; 19(8):453-64. PubMed ID: 16966109
[TBL] [Abstract][Full Text] [Related]
15. Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm.
Marret S; Marchand L; Kaminski M; Larroque B; Arnaud C; Truffert P; Thirez G; Fresson J; Rozé JC; Ancel PY;
Pediatrics; 2010 Jan; 125(1):e29-34. PubMed ID: 20026499
[TBL] [Abstract][Full Text] [Related]
16. Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor.
Smith GN; Walker MC; Ohlsson A; O'Brien K; Windrim R;
Am J Obstet Gynecol; 2007 Jan; 196(1):37.e1-8. PubMed ID: 17240225
[TBL] [Abstract][Full Text] [Related]
17. Mid- and long-term outcome of extremely low birth weight (ELBW) infants: an analysis of prognostic factors.
Valcamonico A; Accorsi P; Sanzeni C; Martelli P; La Boria P; Cavazza A; Frusca T
J Matern Fetal Neonatal Med; 2007 Jun; 20(6):465-71. PubMed ID: 17674256
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit.
Ow LL; Kennedy A; McCarthy EA; Walker SP
Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):356-60. PubMed ID: 22515404
[TBL] [Abstract][Full Text] [Related]
19. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial.
Lyell DJ; Pullen K; Campbell L; Ching S; Druzin ML; Chitkara U; Burrs D; Caughey AB; El-Sayed YY
Obstet Gynecol; 2007 Jul; 110(1):61-7. PubMed ID: 17601897
[TBL] [Abstract][Full Text] [Related]
20. [Use of magnesium sulfate in obstetrics].
Kayem G; Mandelbrot L; Haddad B
Gynecol Obstet Fertil; 2012 Oct; 40(10):605-13. PubMed ID: 22995056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
